Search research articles
Contact Us
Filters
Showing results (21-30 of 295) with videos related to
Page
of 30
Sort By:
Seminars in Oncology
|
November 16, 2011
Alterations of microRNAs contribute to colon carcinogenesis
Aaron J Schetter, Curtis C Harris
Gut
|
September 15, 2009
Plasma microRNAs: a potential biomarker for colorectal cancer?
Aaron J Schetter, Curtis C Harris
Cold Spring Harbor Perspectives in Biology
|
March 20, 2010
Clinical outcomes and correlates of TP53 mutations and cancer
Ana I Robles, Curtis C Harris
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
A primate-specific microRNA enters the lung cancer landscape
Ana I Robles, Curtis C Harris
Lung Cancer (Amsterdam, Netherlands)
|
June 27, 2016
Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer
Ana I Robles, Curtis C Harris
Nature Reviews. Cancer
|
July 9, 2016
Biomarker development in the precision medicine era: lung cancer as a case study
Ashley J Vargas, Curtis C Harris
Journal of the National Cancer Institute
|
April 5, 2017
Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography
Ana I Robles, Curtis C Harris
Aging
|
January 27, 2011
p53 governs telomere regulation feedback too, via TRF2
Izumi Horikawa, Kaori Fujita, Curtis C Harris
Cancer Science
|
September 13, 2006
Japan-US Cooperative Cancer Research Seminar on molecular epidemiological characteristics of lung and colon cancer development among atomic-bomb survivors, Bethesda, USA, February 23-24, 2006
Kei Nakachi, Curtis C Harris, Eiichi Tahara
Carcinogenesis
|
June 20, 2014
Caught in the cross fire: p53 in inflammation
Tomer Cooks, Curtis C Harris, Moshe Oren
Page
of 30
Search research articles
Search
Showing results (21-30 of 295) with videos related to
Sort By:
Page
of 30
Seminars in Oncology
|
November 16, 2011
Alterations of microRNAs contribute to colon carcinogenesis
Aaron J Schetter, Curtis C Harris
Gut
|
September 15, 2009
Plasma microRNAs: a potential biomarker for colorectal cancer?
Aaron J Schetter, Curtis C Harris
Cold Spring Harbor Perspectives in Biology
|
March 20, 2010
Clinical outcomes and correlates of TP53 mutations and cancer
Ana I Robles, Curtis C Harris
Proceedings of the National Academy of Sciences of the United States of America
|
November 6, 2013
A primate-specific microRNA enters the lung cancer landscape
Ana I Robles, Curtis C Harris
Lung Cancer (Amsterdam, Netherlands)
|
June 27, 2016
Integration of multiple "OMIC" biomarkers: A precision medicine strategy for lung cancer
Ana I Robles, Curtis C Harris
Nature Reviews. Cancer
|
July 9, 2016
Biomarker development in the precision medicine era: lung cancer as a case study
Ashley J Vargas, Curtis C Harris
Journal of the National Cancer Institute
|
April 5, 2017
Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography
Ana I Robles, Curtis C Harris
Aging
|
January 27, 2011
p53 governs telomere regulation feedback too, via TRF2
Izumi Horikawa, Kaori Fujita, Curtis C Harris
Cancer Science
|
September 13, 2006
Japan-US Cooperative Cancer Research Seminar on molecular epidemiological characteristics of lung and colon cancer development among atomic-bomb survivors, Bethesda, USA, February 23-24, 2006
Kei Nakachi, Curtis C Harris, Eiichi Tahara
Carcinogenesis
|
June 20, 2014
Caught in the cross fire: p53 in inflammation
Tomer Cooks, Curtis C Harris, Moshe Oren
Page
of 30